Vitamin E significantly improves liver health in MASH patients, new study finds
New research shows that Vitamin E therapy significantly enhances liver function and reduces inflammation in MASH patients, providing a safer ...
Tag: Cirrhosis
HMB supplement trial explores new treatment for chronic liver disease
A dietary supplement used to build muscle – or prevent muscle loss as a result of aging or illness – ...
Evaluating biomarkers for diagnosing minimal hepatic encephalopathy in cirrhotic patients
Background and aims The performance of neurodegenerative biomarkers-neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), tau, and ubiquitin carboxy-terminal ...
Shiitake-based supplement may help prevent liver damage progression
Early use of AHCC during hepatitis stages shows potential to reduce the risk of cirrhosis, according to new research Study: ...
Imbalances in NET homeostasis linked to portal vein thrombosis in CHB-related decompensated cirrhosis
Background and aims Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic ...
Liver function discovery could revolutionize treatments for cardiovascular disease
A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for cardiovascular ...
Study sheds light on mechanisms behind liver fibrosis and potential therapies
New research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis ...
Stretching vs. meditation: New study finds both practices reduce nocturnal muscle cramps in cirrhosis patients
A recent Liver International study investigates the effects of stretching and meditation on nocturnal muscle cramps in patients with cirrhosis. ...
Stroop-CN: A rapid diagnostic tool for minimal hepatic encephalopathy
This study is led by Dr. Xiaolong Qi (Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, ...
Evaluating systemic thrombolysis for acute portal vein thrombosis in cirrhotic patients
The prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% ...
